Literature DB >> 25773419

RASopathic alopecia: hair changes associated with vemurafenib therapy.

Bianca Maria Piraccini1, Annalisa Patrizi1, Pier Alessandro Fanti1, Michela Starace1, Francesca Bruni1, Barbara Melotti2, Cosimo Misciali1, Emi Dika3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25773419     DOI： 10.1016/j.jaad.2015.01.011

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

Review 1.  Cutaneous toxicities of new treatments for melanoma.

Authors:  A Boada; C Carrera; S Segura; H Collgros; P Pasquali; D Bodet; S Puig; J Malvehy
Journal:  Clin Transl Oncol       Date:  2018-05-24       Impact factor: 3.405

Review 2.  Hair disorders in patients with cancer.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Shari Goldfarb; Julie Nangia; Joaquin J Jimenez; Ralf Paus; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2018-04-14       Impact factor: 11.527

Review 3.  Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails.

Authors:  Mario Lacouture; Vincent Sibaud
Journal:  Am J Clin Dermatol       Date:  2018-11       Impact factor: 7.403

4.  Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib.

Authors:  Filip Janku; Albiruni R Abdul Razak; Ping Chi; Michael C Heinrich; Margaret von Mehren; Robin L Jones; Kristen Ganjoo; Jonathan Trent; Hans Gelderblom; Neeta Somaiah; Simin Hu; Oliver Rosen; Ying Su; Rodrigo Ruiz-Soto; Michael Gordon; Suzanne George
Journal:  J Clin Oncol       Date:  2020-08-17       Impact factor: 44.544
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.